Neogenomics Inc (NEO)

EBITDA Growth

168.13%

Quarterly · Period ending:

NEO logo

NEO EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported168.13%
NEO Quarterly EBITDA YoY % (-53.79% → 168.13%)
High-resolution chart · PNG

NEO ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Neogenomics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
168.1306%
91.0157%
24.5385%
-659.73%
-3,753.3069%
18.3465%
-22.5399%
208.8794%
111.458%
45.3085%
157.1772%
92.5928%
67.7942%
51.6739%
67.5522%
-322.1754%
-123.5683%
-170.1931%
-232.2073%
-138.2144%
1,186.032%
-398.8128%
86.3706%
25.1144%
-172.1471%
-30.4665%
17.9458%
16.1421%
87.9702%
-31.5866%
-10.6553%
167.1591%
-15.2742%
48.5948%
201.9266%
-52.65%
-7.6984%
-31.9793%
140.7953%
285.381%
322.0917%
573.7925%
-51.861%
24.1313%
-4.9947%
-30.1686%
20.9691%
-31.8421%
16.0296%
18.5048%
74.1598%
621.519%
-7.3672%
-16.8103%
37.1926%
-43.8721%
385.0416%
828.2511%
1,335.443%
201.8083%
196.5241%
-26.7045%
92.2321%
-75.5556%
-192.4701%
-145.708%
-97.093%
-368.4827%
30.9649%
63.764%
121.4883%
148.9425%
59.2038%
-377.8523%
-371.0081%
-369.2152%
-8.7591%
322.1377%
351.0524%
243.3857%
-10.4839%
26.2634%
22.8421%
-20.1493%
-111.9658%
-9.2217%
-2.6921%
-35.8021%
-107.9863%
49.7254%
-140.9348%
-17.7918%
120.2656%
-27,960.6965%
233.8805%
75.7191%
-1,524.4944%
100.5662%
-4.878%
-126.4924%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.